Healthcare Services

Chemiluminescence Immunoassay Market Forecast 2026–2035 Highlighting Market Data Patterns and Industry Insights

March 31, 2026April 1, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Is The Estimated Market Size Of The Chemiluminescence Immunoassay Market During 2026–2030?

The chemiluminescence immunoassay market size has experienced substantial growth in recent years. This market is projected to expand from $14.85 billion in 2025 to $16.15 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 8.8%. The historical expansion of this market was primarily driven by factors such as a rise in the occurrence of infectious and chronic diseases, the proliferation of centralized diagnostic facilities, an increased need for precise biomarker identification, the broader integration of automated laboratory equipment, and the expanded application of immunoassays in clinical diagnostic procedures.

The chemiluminescence immunoassay market size is anticipated to undergo significant expansion over the next few years. It is projected to reach $22.35 billion by 2030, achieving a compound annual growth rate (CAGR) of 8.5%. The projected growth in this period is driven by factors such as the increasing demand for early disease detection, the rising adoption of personalized medicine diagnostics, the expansion of decentralized testing models, the growing integration of AI-assisted diagnostic interpretation, and increasing investment in advanced clinical laboratory infrastructure. Prominent trends for the forecast period include the increasing adoption of fully automated immunoassay analyzers, a rising demand for high-sensitivity diagnostic kits, the growing use of multiplex testing capabilities, the expansion of rapid and point-of-care CLIA systems, and an enhanced focus on standardized reagent performance.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=27252&type=smp

Which Major Factors Are Driving The Expansion Of The Chemiluminescence Immunoassay Market?

The increasing occurrence of infectious diseases is anticipated to drive the expansion of the chemiluminescence immunoassay market in the future. Infectious diseases are defined as ailments resulting from detrimental microorganisms like bacteria, viruses, fungi, or parasites, which are transmissible between individuals either directly or indirectly. The incidence of infectious diseases is on the rise, primarily because of escalating antimicrobial resistance, which makes standard treatments ineffective and permits infections to linger and spread. Chemiluminescence immunoassays assist in diagnosing infectious diseases by providing highly sensitive and specific detection of biomarkers, thus allowing for the early and precise identification of pathogens. These assays minimize diagnostic delays through the provision of rapid and dependable results, thereby enhancing patient care and therapeutic outcomes. For example, data from February 2024, released by the UK Health Security Agency (a UK-based government body), indicated that tuberculosis (a contagious bacterial infection primarily affecting the lungs) cases in England climbed to 4,850 in 2023, marking a 10.7% increase from the 4,380 cases recorded in 2022. Consequently, the increasing prevalence of infectious diseases is fueling the expansion of the chemiluminescence immunoassay market.

How Are The Various Segments Of The Chemiluminescence Immunoassay Market Categorized?

The chemiluminescence immunoassay market covered in this report is segmented –

1) By Product Type: Analyzers, Kits, Reagents

2) By Sample Type: Blood, Saliva, Urine, Other Samples

3) By Technology: Chemiluminescence Enzyme Technology (CLEIA), Electrochemiluminescence Immunoassay (ECLI), Microparticle Chemiluminescence Immunoassay

4) By Application: Therapeutic Drug Monitoring, Oncology, Cardiology, Endocrinology, Infectious Disease, Autoimmune Disease, Other Applications

5) By End-User: Hospitals, Pharmaceutical And Biotechnology Companies, Clinical Laboratories, Other End-Users

Subsegments:

1) By Analyzers: Fully Automated Analyzers, Semi Automated Analyzers, Portable Analyzers

2) By Kits: Detection Kits, Quantitative Kits, Qualitative Kits, Multiparameter Kits

3) By Reagents: Luminol Reagents, Isoluminol Reagents, Acridinium Ester Reagents, Other Reagents

Which Trends Are Shaping The Future Of The Chemiluminescence Immunoassay Market?

Leading companies in the chemiluminescence immunoassay market are concentrating their efforts on developing advanced products, such as sophisticated chemiluminescence immunoassay analyzers. These innovations aim to elevate test accuracy, boost throughput, and provide more rapid diagnostic results for a diverse range of clinical uses. Chemiluminescence immunoassay analyzers are automated instruments designed to detect and measure light emitted during chemical processes, enabling precise identification of specific biomarkers in diagnostic examinations. For instance, in July 2023, Fapon Biotech Inc., a China-based biotechnology company, unveiled the Shine i8000/9000, a chemiluminescence immunoassay analyzer. This device is engineered for medium to large laboratories, delivering quick initial results within 10 minutes and maintaining high precision, all within a compact, stable, and user-friendly structure. Its principal features include a 360-degree large-span display, one-touch bulk loading for reaction cups, a dual-tube backup substrate system, and automatic reaction cup disposal to reduce contamination. The fully automated workflow lessens manual intervention, and advanced algorithms improve result consistency, making it well-suited for high-volume diagnostic settings.

Which Major Firms Influence Developments In The Chemiluminescence Immunoassay Market?

Major companies operating in the chemiluminescence immunoassay market are F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Shenzhen Mindray Bio-Medical Electronics Co. Ltd., QuidelOrtho Corporation, Sysmex Corporation, Bio-Rad Laboratories Inc., Revvity Inc., DiaSorin S.p.A., Tecan Group Ltd., Euroimmun AG, Randox Laboratories Ltd., Autobio Diagnostics Co. Ltd., Wondfo Biotech Co. Ltd., Fujirebio Diagnostics Inc., Trivitron Healthcare Pvt. Ltd., Getein Biotech Inc., Fapon Biotech Inc., Diazyme Laboratories Inc.

Read the full chemiluminescence immunoassay market report here:

https://www.thebusinessresearchcompany.com/report/chemiluminescence-immunoassay-global-market-report

Which Region Currently Holds The Largest Share Of The Chemiluminescence Immunoassay Market?

North America was the largest region in the chemiluminescence immunoassay market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the chemiluminescence immunoassay market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Chemiluminescence Immunoassay Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=27252&type=smp

Browse Through More Reports Similar to the Global Chemiluminescence Immunoassay Market 2026, By The Business Research Company

Healthcare Chatbots Global Market Report

https://www.thebusinessresearchcompany.com/report/healthcare-chatbots-global-market-report

Chatbot Global Market Report

https://www.thebusinessresearchcompany.com/report/chatbot-global-market-report

Artificial Intelligence Ai Chatbot Global Market Report

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-ai-chatbot-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795